Join
Live feed
·
PRReleasevia Quantisnow
Altamira Therapeutics Ltd. logo

Altamira Therapeutics Announces Significant Enhancement of Immune Checkpoint Inhibition Therapy in Combination with Zbtb46 mRNA Delivered with SemaPhore Nanoparticles in Animal Tumor Models

ByQuantisnow·Wall Street's wire, on your screen.
CYTO· Altamira Therapeutics Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CYTO (Altamira Therapeutics Ltd.) and more on Quantisnow.